Today

Agents

Chat

Arena

Discover

More

App

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering - ZNTL News | Rallies

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

ZNTL•2026-08-13

Proposed underwritten public offering

Aug. 13 (Reuters) - Zentalis Pharmaceuticals Inc. ZNTL.O:

Zentalis Pharmaceuticals announces proposed underwritten public offering.

Related News

MPS director Herbert Chang disposes of 50 common shares worth $71,000

MPWR•2026-08-13

Afya releases investor presentation on Brazil medical education, physician practice solutions ecosystem

AFYA•2026-08-13

Telomir net loss narrows to $1.72 million in Q2 FY26; revenue flat at no revenue

TELO•2026-08-13

Arena Group - Enters Loan Agreement With Renew Group On August 7, 2026

AREN•2026-08-13

Constellation Energy director Roger W. Crandall buys 1,500 shares worth $417,931

CEG•2026-08-13